DocGo (DCGO) Stock Price, News & Analysis

$3.08
-0.12 (-3.75%)
(As of 05/17/2024 ET)
Today's Range
$3.07
$3.22
50-Day Range
$3.02
$4.09
52-Week Range
$2.78
$10.82
Volume
705,580 shs
Average Volume
1.03 million shs
Market Capitalization
$312.84 million
P/E Ratio
15.40
Dividend Yield
N/A
Price Target
$7.75

DocGo MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
151.6% Upside
$7.75 Price Target
Short Interest
Healthy
10.25% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.59mentions of DocGo in the last 14 days
Based on 19 Articles This Week
Insider Trading
Acquiring Shares
$146,150 Bought Last Quarter
Proj. Earnings Growth
-50.00%
From $0.24 to $0.12 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.27 out of 5 stars

Medical Sector

162nd out of 920 stocks

Medical Care Facilities Industry

2nd out of 2 stocks

DCGO stock logo

About DocGo Stock (NASDAQ:DCGO)

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

DCGO Stock Price History

DCGO Stock News Headlines

DocGo (NASDAQ:DCGO) PT Lowered to $5.00
DocGo (NASDAQ:DCGO) Price Target Cut to $7.00
DocGo Announces Strong First Quarter 2024 Results
DocGo Inc. Common Stock (DCGO)
Evaluating DocGo: Insights From 8 Financial Analysts
Peeling Back The Layers: Exploring DocGo Through Analyst Insights
See More Headlines
Receive DCGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
5/18/2024
Next Earnings (Estimated)
8/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
Current Symbol
NASDAQ:DCGO
Fax
N/A
Employees
2,915
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.75
High Stock Price Target
$16.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+151.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$6.86 million
Pretax Margin
5.41%

Debt

Sales & Book Value

Annual Sales
$624.29 million
Cash Flow
$0.20 per share
Book Value
$3.10 per share

Miscellaneous

Free Float
89,816,000
Market Cap
$312.84 million
Optionable
Optionable
Beta
0.96
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Lee Bienstock (Age 39)
    CEO & Director
    Comp: $2.21M
  • Mr. Norman Rosenberg (Age 54)
    Treasurer & CFO
    Comp: $1.43M
  • Mr. Ely D. Tendler (Age 56)
    General Counsel, Secretary & Director
    Comp: $926.37k
  • Mr. Stephen Sugrue (Age 51)
    Chief Compliance Officer
    Comp: $864.35k
  • Mr. Andre Oberholzer CPA (Age 65)
    Executive Vice President of Strategy
    Comp: $1.48M
  • Mike Cole
    Vice President of Investor Relations
  • Ms. Rosemarie Milano
    Vice President of Human Resources
  • Mr. Aaron Severs
    Chief Product Officer
  • Ms. Vrenely Munoz
    Chief Revenue Officer
  • Dr. James Powell
    Chief Executive Officer of Clinical Practice Group

DCGO Stock Analysis - Frequently Asked Questions

Should I buy or sell DocGo stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DCGO shares.
View DCGO analyst ratings
or view top-rated stocks.

What is DocGo's stock price target for 2024?

5 brokers have issued 12 month price targets for DocGo's stock. Their DCGO share price targets range from $5.00 to $16.00. On average, they expect the company's stock price to reach $7.75 in the next year. This suggests a possible upside of 151.6% from the stock's current price.
View analysts price targets for DCGO
or view top-rated stocks among Wall Street analysts.

How have DCGO shares performed in 2024?

DocGo's stock was trading at $5.59 at the beginning of 2024. Since then, DCGO stock has decreased by 44.9% and is now trading at $3.08.
View the best growth stocks for 2024 here
.

When is DocGo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 5th 2024.
View our DCGO earnings forecast
.

How were DocGo's earnings last quarter?

DocGo Inc. (NASDAQ:DCGO) posted its earnings results on Wednesday, February, 28th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.07. The company had revenue of $199.25 million for the quarter, compared to the consensus estimate of $195.48 million. DocGo had a trailing twelve-month return on equity of 6.20% and a net margin of 2.98%.

What ETF holds DocGo's stock?

Global X Telemedicine & Digital Health ETF holds 96,570 shares of DCGO stock, representing 0.69% of its portfolio.

What guidance has DocGo issued on next quarter's earnings?

DocGo issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $600.0 million-$650.0 million, compared to the consensus revenue estimate of $714.3 million.

Who are DocGo's major shareholders?

DocGo's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (4.66%), WCM Investment Management LLC (2.52%), Kennedy Capital Management LLC (1.42%), Isthmus Partners LLC (0.58%), Pasadena Private Wealth LLC (0.38%) and Janus Henderson Group PLC (0.33%). Insiders that own company stock include Adriaan Stephanus Oberholzer, Anthony Capone, Ely D Tendler, James M Travers, Lee Bienstock, Michael J Burdiek and Stephen Sugrue.
View institutional ownership trends
.

How do I buy shares of DocGo?

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DCGO) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners